Selective effect of levocabastine on histamine receptor and histamine release from human leukocytes and guinea pig isolated tissue

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 4, 1996, Pages 327-334

  Garrelds, Ingrid M ^a   De Graaf in't Veld, Tineke ^a   Van Toorenenbergen, Albert W ^a   Van Wijk, Roy Gerth ^a   Boegheim, J Pierre J ^b   Saxena, Pramod R ^a   Zijlstra, Frederik J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Janssen Cilag BV Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; HISTAMINE RECEPTOR; INTERLEUKIN 5; LEVOCABASTINE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOLYSIS; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; LEUKOCYTE; MAST CELL; MUSCLE CONTRACTION; PRIORITY JOURNAL; SWINE;

EID: 15844363619     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60033-6     Document Type: Article

References (41)

1. 1-antihistaminic activity. Drug Dev Res 1986;8:87-93.
2. Dechant KL, Goa KL. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical amihistamine in allergic rhinitis and conjunctivis. Drugs 1991;41: 202-24.
3. 1 receptor antagonist therapy. Clin Pharmacokinet 1991;21:372-93.
4. Mygind N. Mediators of nasal allergy. J Allergy Clin Immunol 1982;70: 149-59.
5. Naclerio RM, Togias AG, Proud D, et al. Understanding the pathogenesis of allergic rhinitis. In: Mygind N, Naclerio R, eds. Rhinoconjuctivitis. Toronto: Hogrefe and Huber. 1989: 7-18.
6. Van de Heyning PH, Claes J, Van Haesendonck J, Rosseel M. A gap in surface therapy: topical antihistamines. Clin Exp Allergy 1991;21(Suppl 2): 21-7.
7. 1 receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen. Br J Clin Pharmac 1986; 22:389-94.
8. Pazdrak K, Górski P, Ruta U. Inhibitory effect of levocabastine on allergen-induced increase of nasal reactivity to histamine and cell influx. Allergy 1993;48:598-601.
9. De Graaf-in't Veld C, Garrelds IM, et al. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in patients with perennial rhinitis. Ann Allergy 1995 (In press).
10. Ishizaka T, Ishizaka K, Johansson SGO, Bennich H. Histamine release from human leukocytes by anti-τE antibodies. J Immunol 1969;102:884-9.
11. Plaut M, Pierce JH, Watson CJ, et al. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989;339:64-7.
12. Schleimer RP, MacGlashan DW Jr, Peters SP, et al. Inflammatory mediators and mechanism of release from purified human basophils and mast cells. J Allergy Clin Immunol 1984;74: 473-81.
13. Gomez E, Corrado OJ, Baldwin DL, et al. Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man. J Allergy Clin Immunol 1986;78:637-45.
14. Holgate ST, Hardy CC, Robinson C, et al. The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol 1986;77: 274-82.
15. Iliopoulos O, Baroody FM, Naclerio RM, et al. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992;148:2223-8.
16. Lichtenstein LM, Osier AG. Studies on the mechanisms of hyperreactivity phenomena. IX Histamine release from human leukocytes by ragweed pollen antigen. J Exp Med 1964;120: 507-30.
17. Siraganian RP, Hook WA. Histamine release and assay methods for the study of human allergy. In: Rose NR, Friedman H, eds. Manual of clinical immunology. 2nd ed. Washington DC: Am Soc Microbiol 1980;808-21.
18. Lau HYA, Pearce EL. Dual effect of antihistamines on rat peritoneal mast cells: induction and inhibition of histamine release. Agents Actions 1985;16: 176-8.
19. Lau HYA, Pearce EL. Effects of antihistamines on isolated mast cells from the rat, guinea pig and man. Agents Actions 1986;18:107-9.
20. Mota I, Dias da Silva W. The antianaphylactic and histamine-releasing properties of the antihistamines. Their effect on the mast cells. Br J Pharmacol 1960;15:396-404.
21. De Week AL, Derer T, Bischoff SC, Takajuji S. The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E. Int Arch Allergy Immunol 1993;101: 326-32.
22. De Jongste JC, Mons H, Van Strik R, et al. Comparison of isometric and isotonic responses of human small airway smooth muscle in vitro. J Pharmacol Methods 1987;17:165-71.
23. Andersson M, Nolte H, Baumgarten C, Pipkorn U. Suppressive effect of loratidine on allergen-induced histamine release in the nose. Allergy 1991;46: 540-6.
24. 1 receptor antagonist assessed by nasal challenge. J Allergy Clin Immunol 1988;82:881-7.
25. Church MK, Gradidge CF. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol 1980;69:663-7.
26. Faraj BA, Jackson RT. Effect of astemizole on antigen-mediated histamine release from the blood of patients with allergic rhinitis. Allergy 1992;47: 630-4.
27. 1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro. Clin Exp Allergy 1993;23:399-405.
28. 1antagonist loratidine on histamine release from human basophils. Int Arch Allergy Immunol 1994;105:12-7.
29. Nabe M, Agrawal DK, Sarmiento EU, Townley RG. Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils. Clin Exp Allergy 1989;19:515-20.
30. 1-antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990;142:167-71.
31. Peachell PT, Pearce FL. Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells. Br J Pharmacol 1989; 97:547-55.
32. 1-antihistamine compound levocabastine. Arzneim Forsch Drug Res 1993; 43:1331-6.
33. Tasaka K, Mitsunobu M, Masahiro O. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy 1986;56:464-9.
34. 45calcium uptake by mast cells. J Physiol 1977;271:193-214.
35. 2+ fluxes and histamine release in rat mast cells stimulated with compound 48/80. Agents Actions 1984;15: 279-84.
36. Akagi W, Mio M, Tasaka K. Histamine release inhibition and prevention of the decrease in membrane fluidity induced by certain anti-allergic drugs: analysis of the inhibitory mechanism of NCO-650. Agents Actions 1983;13: 149-56.
37. 3 receptors. Allergy 1991;46:626-31.
38. Garrelds IM, De Graaf-in't Veld T, Nahori M-A, et al. Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients. Eur J Pharmacol 1995;275:295-300.
39. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
40. Alam R, Grant JA. Basophils: biology and function in airway disease. In: Busse WVV, Holgate ST, eds. Asthma and rhinitis. Cambridge, Massachusetts: Blackweil Scientific Publications, 1995;20: 242-51.
41. Rang HP, Dale MM. Pharmacology 2 ed. New York: Churchill Livingstone, pp 259.